Cambridge-based Dyax to raise $15M: Careers at Dyax

Cambridge-Based Dyax to Raise $15 Million in Public Offering


Cambridge, Mass. -- Dyax, a Cambridge-based developer of
drugs for unmet medical needs such as inflammatory diseases and cancer, said on
Thursday that it will raise approximately $15 million through a public offering,
selling 7.4 million shares for $2.02 each. The company also will grant
underwriters the option to buy another 1.1 million shares, to cover any
over-allotments. The offering is expected to close on Tuesday, with proceeds
going to fund the development and commercialization of DX-88, a drug designed to
prevent blood loss during on-pump cardiothoracic surgery (CTS).
http://www.dyax.com 

http://finance.yahoo.com/news/Dyax-Announces-15-Million-bw-1224461035.html?x=0&.v=1 

Career Opportunities at Dyax